Munich, Georgia

Siegfried Maeke


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kirchdorf, DE (1979)
  • Raubling-Kirchdorf, DE (1986 - 1988)

Company Filing History:


Years Active: 1979-1988

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Siegfried Maeke

Introduction

Siegfried Maeke, located in Raubling-Kirchdorf, Germany, is a notable inventor recognized for his contributions to the field of pharmacology. With three patents to his name, Maeke has made significant advancements in developing crucial intermediates for producing pharmacologically active compounds.

Latest Patents

Among Maeke's recent patents, the compounds 4-amino-3-imidazolin-2-one and (2-methoxy-2-iminoethyl)urea stand out as valuable intermediates. These innovations play a critical role in the synthesis of various pharmacologically active substances, showcasing his expertise in pharmaceutical chemistry.

Career Highlights

Maeke is associated with Diamalt Aktiengesellschaft, a company where he has been able to leverage his skills and knowledge in inventing. His dedication to research and development reflects the commitment to advancing healthcare through innovative solutions.

Collaborations

Throughout his career, Maeke has collaborated with esteemed colleagues such as Adolf Bauer and Hubert Vogt. These partnerships emphasize the collaborative nature of innovation in the field, leading to groundbreaking inventions and advancements in pharmacological products.

Conclusion

Siegfried Maeke's inventive accomplishments highlight his significant role in the pharmaceutical industry. With his latest patents fostering the development of valuable compounds, he continues to contribute to the progress and innovation within the realm of pharmacology. His work not only exemplifies the importance of collaboration in the field but also enhances the potential for future discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…